Lyrica Overview

  • Status
  • Private

Lyrica General Information


Provider of oral drugs. The company provides oral medicines developed for the treatment of neuropathic pain and treats two of the most common forms of nerve pain, namely diabetic peripheral neuropathy ("DPN") and post-herpetic neuralgia ("PHN") and is applicable to a broad range of other disorders.

Contact Information

Ownership Status
Privately Held (no backing)
Financing Status
Primary Industry
Drug Delivery
Primary Office
  • 235 East 42nd Street
  • New York, NY 10017
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more